Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Conte

Showing results (331-340 of 368) with videos related to

Pageof 37
Sort By:
Journal of Molecular Neuroscience : MN|February 5, 2009
Expression profile and distribution of Efhc1 gene transcript during rodent brain developmentFábio F Conte, Patrícia A O Ribeiro, Rafael B Marchesini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statementsD G Allen, J Baak, D Belpomme, et al.
Tumori|March 1, 1997
Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicityM Bertuccelli, F Cartei, A Falcone, et al.
British Journal of Cancer|March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyC Bengala, C Zamagni, P Pedrazzoli, et al.
British Journal of Cancer|March 10, 2011
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancerF Bertolini, N Malavasi, L Scarabelli, et al.
British Journal of Cancer|June 30, 2005
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinomaC Bengala, V Guarneri, E Giovannetti, et al.
International Journal of Obesity (2005)|January 11, 2014
Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatmentT Cadoudal, M Buléon, C Sengenès, et al.
American Journal of Clinical Oncology|February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap studyA Ardizzoni, G Antonelli, S Ricci, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)C Tibaldi, S Ricci, F Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2008
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancerC Bengala, S Bettelli, F Bertolini, et al.
Pageof 37

Showing results (331-340 of 368) with videos related to

Sort By:
Pageof 37
Journal of Molecular Neuroscience : MN|February 5, 2009
Expression profile and distribution of Efhc1 gene transcript during rodent brain developmentFábio F Conte, Patrícia A O Ribeiro, Rafael B Marchesini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statementsD G Allen, J Baak, D Belpomme, et al.
Tumori|March 1, 1997
Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicityM Bertuccelli, F Cartei, A Falcone, et al.
British Journal of Cancer|March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyC Bengala, C Zamagni, P Pedrazzoli, et al.
British Journal of Cancer|March 10, 2011
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancerF Bertolini, N Malavasi, L Scarabelli, et al.
British Journal of Cancer|June 30, 2005
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinomaC Bengala, V Guarneri, E Giovannetti, et al.
International Journal of Obesity (2005)|January 11, 2014
Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatmentT Cadoudal, M Buléon, C Sengenès, et al.
American Journal of Clinical Oncology|February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap studyA Ardizzoni, G Antonelli, S Ricci, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)C Tibaldi, S Ricci, F Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2008
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancerC Bengala, S Bettelli, F Bertolini, et al.
Pageof 37